Craig Stewart

Title: Craig Stewart: Innovator in Pharmaceutical Chemistry

Introduction

Craig Stewart is a notable inventor based in Natick, MA (US), recognized for his contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, he has made significant strides in the field, particularly in the area of Syk inhibitors.

Latest Patents

Craig Stewart holds 2 patents that showcase his expertise. His latest patents include the crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor. These patents detail the solid forms of the compound and the processes for making these solid forms, along with methods of use. Additionally, he has developed crystalline forms of the same compound, further enhancing its potential applications in medicine.

Career Highlights

Craig Stewart is currently employed at Kronos Bio, Inc., where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the understanding and application of Syk inhibitors, which are crucial in treating various diseases.

Collaborations

Throughout his career, Craig has collaborated with esteemed colleagues, including Patricia Andres and Peter C Fung. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Craig Stewart's contributions to the field of pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a leading inventor. His work at Kronos Bio, Inc. and collaborations with other professionals underscore his commitment to advancing medical science.